" I knew from the first session that Alex really cares about his patients and wants to see them reach their healthy state, I have never had any health care provider take the time that Alex did to answer all of my questions and be there via email or phone if I needed to follow up after our initial consultation. I have been incorporating a herbal daily regime and including acupuncture and I have experienced positive changes even after Alex told me it could take up to two years for my body to get back to a full healthy stage. Not only do I receive acupuncture during each visit, I also have a follow up discussion with Alex to express any concerns and my progress. Alex is very warming, welcoming and is very educated, he has given me various exercise techniques to help with my symptoms along with been a therapist by helping me open up about the problems I have faced in life and how to best handle them so they do not haunt my body long term."
-An up to 2-fold increased risk of having breast cancer diagnosed is reported in women taking combined estrogen-progestin therapy for more than 5 years.
-Any increased risk in users of estrogen-only therapy is substantially lower than that seen in users of estrogen-progestin combinations. The level of risk is dependent on the duration of use.
-Endometrial cancer risk is about 5 in every 1000 women with a uterus not using HRT.
-In women with a uterus, use of estrogen-only HRT is not recommended because it increases the risk of endometrial cancer.
-Depending on the duration of estrogen-only use and estrogen dose, the increase in risk of endometrial cancer varied from between 5 and 55 extra cases diagnosed in every 1000 women between the ages of 50 and 65.
-Adding a progestin to estrogen-only therapy for at least 12 days per cycle can prevent this increased risk. In the Million Women Study the use of five years of combined HRT did not increase risk of endometrial cancer.
-Long-term use of estrogen-only and combined estrogen-progestin HRT has been associated with a slightly increased risk of ovarian cancer. In the Million Women Study 5 years of HRT resulted in 1 extra case per 2500 users. [ Ref ]
While all of this seems to paint Estrogen and its prostate-related side effects in a very grave light, there is some saving grace to Estrogen. There is evidence that in addition to the negative estrogenic side effects as it relates to the prostate, it also seems to exhibit some beneficial protective effects as well  . On the positive side, the stimulation of Estrogen receptor-beta can assist in the protection of the prostate from inflammation, hyperplasia, and some carcinogenesis. It is the Estrogen receptor-alpha that is responsible for negative effects mentioned earlier. It is safe to conclude, however, that a very high level of Estrogen seems more harmful for the prostate than beneficial as elevated levels of PSA have been recorded during anabolic steroid administration (both mild and heavily estrogenic anabolic steroids were used)  .